Per previous terms of clearance--and given that the burden estimates continue to swing dramatically from submission to submission--approval is granted for 2 years so that the estimates are more frequently updated. Where burden estimates swing dramatically, FDA should attempt to reassess estimates more frequently to ensure that the estimates on record are accurate. To the extent that the swings are actually due to poor estimation, FDA should attempt to improve the way estimates are produced.
Inventory as of this Action
Requested
Previously Approved
10/31/2011
36 Months From Approved
10/31/2009
64,805,294
0
2,702,413
2,629,106
0
2,702,413
0
0
0
The regulations that are the subject of this information collection implement PDMA. PDMA was enacted by Congress because there were insufficient safeguards in the drug distribution system to prevent the introduction and retail sale of substandard, ineffective, or counterfeit drugs, and that a wholesale drug diversion submarket had developed that prevented effective control over the true sources of drugs. Congress found, amont other things, that large amounts of drugs had been reimported into the U.S. as U.S. goods returned causing a health....
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.